Skip to main content

Half of Young Cancer Patients Report Fertility Preservation Discussion With Provider

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 19, 2024.

via HealthDay

TUESDAY, Nov. 19, 2024 -- Many young patients with early-onset cancer report having a fertility preservation (FP) discussion with their health care professional prior to treatment, according to a research letter published online Nov. 12 in JAMA Network Open.

Samantha R. Keller, from Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues evaluated FP discussion patterns as reported by 473 patients (men, 18 to 49 years; women, 18 to 42 years) with a first primary early-onset cancer (diagnosis between 2013 and 2021) participating in the Reproductive Health After Cancer Diagnosis & Treatment Study.

The researchers found that half of patients (50.7 percent) reported that a health care professional involved in their cancer care discussed FP options before treatment initiation, but there were significant differences in the proportion reporting FP discussions by age, pregnancy history, and marital status. Young patients with thyroid, lung or bronchus, ovarian, and colorectal cancers (3.6, 21.0, 21.4, and 44.2 percent, respectively) reported the lowest prevalence of FP discussions.

"If FP was discussed by the health care professional but the patient did not understand or recall this information, our findings may underreport the true prevalence of patient-recalled FP discussions in the clinical setting," the authors write.

Several authors disclosed ties to pharmaceutical companies.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Adding Pembrolizumab to Standard Care Ups Event-Free Survival in Head, Neck Cancer

FRIDAY, June 27, 2025 -- For patients with locally advanced head and neck squamous cell carcinoma (HNSCC), the addition of neoadjuvant and adjuvant pembrolizumab to standard care...

Telehealth Intervention Beneficial for Seniors With Metastatic Cancer

WEDNESDAY, June 25, 2025 -- The telehealth-administered Geriatric Assessment–Guided Intervention (GAIN-S) improves physical function, mood, quality of life, and prognostic...

Incidence Rates of Appendiceal Adenocarcinoma Increasing

MONDAY, June 16, 2025 -- The incidence rates of appendiceal adenocarcinoma (AA) increased after 1945, according to a study published online June 10 in the Annals of Internal...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.